Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Oleanolic Acid Capsules | 国药准字H32026350 | 化学药品 | 胶囊剂 | 5/12/2020 | |
| Oleanolic Acid Capsules | 国药准字H20057700 | 化学药品 | 胶囊剂 | 2/12/2020 | |
| Oleanolic Acid Capsules | 国药准字H11021856 | 化学药品 | 胶囊剂 | 11/2/2020 | |
| Fuzheng Nuzhensu Pian | 国药准字H13024386 | 化学药品 | 片剂 | 9/22/2020 | |
| Oleanolic Acid Tablets | 国药准字H37022327 | 化学药品 | 片剂 | 3/20/2025 | |
| Oleanolic Acid Tablets | 国药准字H14021316 | 化学药品 | 片剂 | 12/29/2020 | |
| Oleanolic Acid Tablets | 国药准字H11021348 | 化学药品 | 片剂 | 11/27/2020 | |
| Oleanolic Acid Tablets | 国药准字H61021861 | 化学药品 | 片剂 | 2/10/2022 | |
| Oleanolic Acid Tablets | 国药准字H44020134 | 化学药品 | 片剂 | 2/12/2020 | |
| Oleanolic Acid Tablets | 国药准字H22023274 | 化学药品 | 片剂 | 12/31/2021 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||